<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04196114</url>
  </required_header>
  <id_info>
    <org_study_id>STIMO-2</org_study_id>
    <nct_id>NCT04196114</nct_id>
  </id_info>
  <brief_title>Study on Feasibility of Stimulation on the Lumbar Part of the Spinal Cord to Improve Mobility Recovery in Patients With Sub-acute Spinal Cord Injury</brief_title>
  <acronym>STIMO-2</acronym>
  <official_title>Study on Feasibility of Targeted Epidural Spinal Stimulation to Improve MObility Recovery in Patients With Sub-acute Spinal Cord Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ecole Polytechnique Fédérale de Lausanne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ecole Polytechnique Fédérale de Lausanne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The STIMO-2 study aims to investigate TESS-supported rehabilitation training in sub-acute&#xD;
      spinal cord injury (&lt; 6 months post-injury). The primary endpoint of this study is to assess&#xD;
      the safety and feasibility of TESS. The preliminary effectiveness of the therapy is the&#xD;
      secondary study endpoint. The mobility recovery status of patients, who undergo&#xD;
      TESS-supported rehabilitation, will be assessed at 12 months post SCI, compared to their&#xD;
      predicted recovery expectations based on standard rehabilitation program&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Study on-hold before first recruitment&#xD;
  </why_stopped>
  <start_date type="Anticipated">February 1, 2022</start_date>
  <completion_date type="Anticipated">March 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety Measure: occurence of Serious Adverse Event</measure>
    <time_frame>Through study completion, until 12 months after injury</time_frame>
    <description>Occurrence of Serious Adverse Event that are deemed related or possibly related to study procedure or to study investigational system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Feasibility Measure: use of TESS stimulation (in minutes) for improved mobility</measure>
    <time_frame>Through study completion, until 12 months after injury</time_frame>
    <description>Measure of the absolute and relative usage of TESS (in minutes) during mobility rehabilitation sessions.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Preliminary effectiveness: assessment of function recovery of leg motor function using the 6 mnWT distance</measure>
    <time_frame>Through study completion, until 12 months after injury</time_frame>
    <description>This endpoint will compare each patient's 6mnWT distance at 12 months post Date Of Injury to historical controls.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preliminary effectiveness: mobility assessment using SCIM-III mobility score</measure>
    <time_frame>Through study completion, until 12 months after injury</time_frame>
    <description>This endpoint will compare each patient's SCIM-III mobility score at 12 months post Date Of Injury to historical controls.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Spinal Cord Injury</condition>
  <arm_group>
    <arm_group_label>All patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients implanted.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>STIMO-2 device implantation</intervention_name>
    <description>Implantation of SCS lead in epidural space and implantation of neurostimulator in abdominal region</description>
    <arm_group_label>All patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria (non-exhaustive list)&#xD;
&#xD;
          -  Patient enrolled in the EMSCI study&#xD;
&#xD;
          -  Age 18 to 70 years old included&#xD;
&#xD;
          -  Focal spinal cord injury due to trauma&#xD;
&#xD;
          -  Patient with history of SCI within the past 6 months (sub-acute SCI)&#xD;
&#xD;
          -  Vertebral lesion T11 or above&#xD;
&#xD;
          -  Psychological condition compatible with study participation&#xD;
&#xD;
          -  Able and willing to fulfil all study procedures&#xD;
&#xD;
        Exclusion criteria (non-exhaustive list)&#xD;
&#xD;
          -  Severe or chronic medical disorder pre-existing SCI affecting rehabilitation&#xD;
&#xD;
          -  Active implanted device such as a pacemaker, implantable cardiac defibrillator&#xD;
&#xD;
          -  Inability to follow study procedures, e.g. due to language problems, psychological&#xD;
             disorders, dementia&#xD;
&#xD;
          -  Pregnant or breast feeding&#xD;
&#xD;
          -  Participation in other interventional study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHUV</name>
      <address>
        <city>Lausanne</city>
        <state>Vaud</state>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>December 5, 2019</study_first_submitted>
  <study_first_submitted_qc>December 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 12, 2019</study_first_posted>
  <last_update_submitted>March 22, 2021</last_update_submitted>
  <last_update_submitted_qc>March 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ecole Polytechnique Fédérale de Lausanne</investigator_affiliation>
    <investigator_full_name>Jocelyne Bloch</investigator_full_name>
    <investigator_title>Coordinating investigator</investigator_title>
  </responsible_party>
  <keyword>spinal cord injury</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

